StrengthsAs referenced already, the Swedish national competent authority is very highly regarded and it has played a significant role with the European Medicines Agency since the formation of the European agency. The Stockholm-Uppsala region also hosts several world leading academic institutions and world-leading pharmaceutical and life science companies.
- Astra AB
- Astra Zeneca
WeaknessesAgain, as referenced in an earlier paragraph, the fact that the ECDC is housed in Sweden might play a part in the undoing of the bid. However, it would be short-sighted of the decision-makers to discount this bid, and many other, for this reason when they can offer a viable home to such a large agency. As weaknesses go, we see this as a minor worry rather than a substantial issue.